Avicenna Alliance provided feedback on the Revision of the EU general pharmaceuticals legislation
On 27 April, the Avicenna Alliance has submitted its feedback to the revision of the EU general pharmaceuticals legislation. Through this feedback, Avicenna Members provided the European Commission with guidance on how to meet unmet medical needs, maintain a system of incentives, promote evidence generation tools for marketing authorisation of innovative medicines, and support and accelerate product development and authorisation. We encourage all members to have a read through the feedback given by the Avicenna Alliance which you can find in this PDF.
